Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-09

FDA Approved: CELECOXIB — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for Celecoxib from Micro Labs Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

SUPPL AP for CELECOXIB (CELECOXIB)